Dr. Amish Dave discusses how his volunteer, advocacy & public outreach work stem from his greater commitment to community & helping others.
5 Rheumatology Resources Every Internal Medicine Resident Should Know
A second-year internal medicine resident shares five ACR resources (plus an app) for residents navigating the complexities of rheumatology.
ACR Advocates for Fair Reimbursement & Telehealth Flexibility in MPFS 2026 Proposed Rule
In comments to the CMS, the ACR advocated for telehealth flexibilities and fair reimbursement and pushed back on proposed efficiency adjustments and changes likely to increase administrative burden on practices.
What to Expect in Chicago at the Practice Innovation Summit
The Practice Innovation Summit, to be held in Chicago Oct. 24–25, offers a roadmap to a smarter, stronger rheumatology practice, led by experts in operations, coding, financial sustainability and more.
How AI Can Make Clinical Rheumatology Research More Efficient & Fruitful
A rheumatologist with a background in biostatistics, data science & bioinformatics discusses the use of artificial intelligence in clinical research.
ACR President Warns: Access to Care Is at Risk Without Medicare Payment Reform
In a recent commentary published by Medscape, ACR President Carol Langford, MD, MHS, issues a stark warning: If Congress does not reform the physician payment system, patients may face increasing difficulty accessing essential medical services.
Celebrating Interdisciplinary Collaboration: Pathways to Success
Four past ARP presidents mark the organization’s 60th anniversary by examining its evolution alongside significant challenges & opportunities in the field.
How to Diagnose Sjögren’s Disease
Improve your Sjögren’s disease diagnosis. Experts discuss objective testing, seronegative cases, ILD screening & management strategies.
Medical Liability Reform Position Statement Now Addresses Harmful Payer Policies, Telemedicine Authorization & Patient Compensation
The largest changes include additions that address harmful payer policies, telemedicine authorization and patient compensation funds.
UHC Formulary Change Impacts Coverage for Ustekinumab
Effective Sept. 1, the brand name drug Stelara will no longer be covered on the UnitedHealthcare commercial plan prescription drug list.
- 1
- 2
- 3
- …
- 171
- Next Page »